August 22, 2016 / 1:02 PM / a year ago

BRIEF-VBI Vaccines to continue Phase I Trial of its CMV Vaccine Candidate

Aug 22 (Reuters) - Vbi Vaccines Inc

* Data safety monitoring board has no objection to co continuing enrollment in phase i clinical study to evaluate preventative cytomegalovirus vaccine candidate

* Says will continue to share clinical trial safety data with Health Canada periodically throughout study Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below